Comparison of high sensitive c reactive protein levels between metabolically healthy and unhealthy obese

Abstract

Introduction Differentiating between metabolically healthy and unhealthy obesity is critical for assessing cardiovascular and metabolic risk. High-sensitivity C-reactive protein (hs-CRP), a key marker of systemic inflammation, has emerged as a potential tool for this purpose. This literature review synthesizes key findings on the association between hs-CRP levels and metabolic health status in obese individuals.

Methods This study is a comprehensive literature review that analyzes and synthesizes findings from seven pivotal articles published between 2012 and 2022. The review examines the role of hs-CRP as an inflammatory biomarker and its correlation with components of metabolic syndrome, adiposity, gender differences, and other determinants in obese populations.

Results The synthesized literature consistently demonstrates that elevated hs-CRP levels are strongly associated with metabolic syndrome in obese individuals. Central obesity is a primary driver of this low-grade chronic inflammation, which is mediated by the release of pro-inflammatory cytokines from adipose tissue that elevate serum hs-CRP. Findings indicate that individuals with metabolic syndrome have markedly higher hs-CRP levels than their metabolically healthy counterparts , with some evidence suggesting a more pronounced inflammatory response in women.

Discussion The evidence collectively indicates that hs-CRP reflects the underlying pathophysiological link between excess adiposity and metabolic dysfunction. The chronic inflammatory state indicated by elevated hs-CRP is a key factor that differentiates metabolically unhealthy from healthy obesity, suggesting that Body Mass Index (BMI) alone is an insufficient measure of an individual's health risk.

Conclusion Elevated hs-CRP is a reliable and crucial biomarker for identifying metabolic dysfunction in obese individuals. Its use in clinical practice is valuable for differentiating between metabolically healthy and unhealthy states, thereby allowing for more accurate cardiovascular risk stratification and targeted interventions in this population.